disclaimer
play

DISCLAIMER The following presenta?on contains data provided to OMG. - PowerPoint PPT Presentation

ORGANIC MEDICAL GROWTH OMG3 INC CORPORATE PRESENTATION Q2 2019 www.bestppt.com DISCLAIMER The following presenta?on contains data provided to OMG. As such, OMG has taken all reasonable care in reproducing the informa?on herein. Material in this


  1. ORGANIC MEDICAL GROWTH OMG3 INC CORPORATE PRESENTATION Q2 2019 www.bestppt.com

  2. DISCLAIMER The following presenta?on contains data provided to OMG. As such, OMG has taken all reasonable care in reproducing the informa?on herein. Material in this presenta?on may contain technical or other inaccuracies, omissions, or typographical errors, for which OMG assumes no responsibility. OMG does not warrant or make any representa?ons regarding the use, validity, accuracy, completeness or reliability of any claims, statements or informa?on in this presenta?on. Under no circumstances, including, but not limited to, negligence, shall OMG be liable for any direct, indirect, special, incidental, consequen?al, or other damages, including but not limited to, loss of programs, loss of data, loss of use of computer of other systems, or loss of profits, whether or not advised of the possibility of damage, arising from the use, or inability to use, the material in this presenta?on. The informa?on presented herein is not a subs?tute for independent professional advice before making investment decisions. FORWARD-LOOKING STATEMENTS This presenta?on may contain forward-looking statements, including but not limited to comments regarding predic?ons and projec?ons. Forward-looking statements address future events and condi?ons and therefore involve inherent risks and uncertain?es. Actual results may differ materially from those currently an?cipated in such statements. www.bestppt.com

  3. COMPANY PURPOSE BRANDS OIL INTERNATIONAL OMG’s purpose is to transform and LABS distribute cannabis deriva?ves and products throughout Colombia and other interna?onal markets. OMG secures raw materials through 8,350 PHARMACIES the produc?on of its mul?ple Licensed Producers (LPs) on organic cer?fied LP LP BIOMASS farms throughout Colombia. LP LP 3 www.organicmedicalgrowth.com

  4. CHALLENGES • Colombian cannabis industry is s?ll in the early development stage. • The prac@ces to produce cannabis in Colombia are not standardized . • Licensed producers have limited access to technology and partners who have transforma?on, distribu?on, export and finance exper?se. • Many licenses are being revoked for various reasons. • Licensed producers are asking for large sums of money for the purchase of sub-standard opera?ons. • Financing for cannabis within Colombia is extremely challenging. 4 www.organicmedicalgrowth.com

  5. THE SOLUTION • OMG will finance and consolidate the produc?on of mul?ple Licensed Producers (LP). • OMG has access to mul?ple licenses in each category including: seed licenses, non-psychoac@ve licences, psycho-ac@ve licenses, transforma@on licenses and export licenses. • OMG will provide world-class exper@se and technology in cannabis produc?on, cul?va?on and extrac?on. • Distribu?on to more than 8,350 pharmacies throughout Colombia. • Finalizing distribu@on (off-take) agreements in Germany, Australia and Portugal for the cannabis oil. 5 www.organicmedicalgrowth.com

  6. WHY INVEST IN OMG • Global cannabis oil awakening : Growing appe?te and worldwide demand for low-cost high-standard oil. • Legal framework in Canada and Colombia: Ability to raise money in Canada and produce in Colombia. • Growing condi?ons: Produc?on costs in Colombia are $0.05 CAD per gram compared to around $1.50 CAD per gram in Canada . This is due to lower wages and beZer growing condi?ons across Colombia. • Only one year a[er the legaliza?on of large-scale produc?on, Colombia is poised to be the largest cannabis producer in the world with 44% of the world produc@on authorized by the Interna?onal Narco?cs Control Board (INCB) for this year. 6 www.organicmedicalgrowth.com

  7. MARKET POTENTIAL • Cannabis is expected to disrupt virtually every consumer industry. Legal cannabis became a US$12 billion global market in 2018 with exponen?al growth ahead. (1) • While the total global market for cannabis, both legal and illegal, stands at US$150 billion today, the global market research company Euromonitor Interna?onal expects the legal market to grow to 77% of total sales, reaching US$166 billion by 2025 . (2) • Medical marijuana emerged as the largest marijuana type segment in 2016 and is es?mated to be valued at $US100.03 billion by 2025. CBD market will hit $US22 billion by 2022. (3) • In Colombia, the emerging cannabis industry has the opportunity to supply an es?mated market of 6 million pa@ents . (4) (1) BusinessWire (February 2019) Global Legal Cannabis Market to Reach US$166 Billion by 2025. https://www.businesswire.com/news/home/20190226005126/en/Global-Legal-Cannabis-Market-Reach-US166-Billion (2) BusinessWire (February 2019) Global Legal Cannabis Market to Reach US$166 Billion by 2025. https://www.businesswire.com/news/home/20190226005126/en/Global-Legal-Cannabis-Market-Reach-US166-Billion 7 (3) The BrightField Group: CBD Market Report (September 2018) Exclusive: New Report Predicts CBD Market Will Hit $22 Billion by 2022. https://www.rollingstone.com/culture/culture-news/new-study-cbd-market-22-billion-2022-722852/ (4) Cannabis Investing News. (December 2018) Latin America’s Emerging Medical Cannabis Market. https://investingnews.com/innspired/latin-americas-medical-cannabis-market/ www.organicmedicalgrowth.com

  8. COMPETITION / ALTERNATIVES LICENSES 8 LICENSED PRODUCERS: 3 LICENSED PRODUCERS 3 LICENSED PRODUCERS (COLOMBIA, 1 LICENSED PRODUCER: 8 LICENSED PRODUCERS 5 NON-PSYCHOACTIVE LICENSES, (2 COLOMBIA, 1 ARGENTINA) CHILE, URUGUAY) 1 NON-PSYCHOACTIVE LICENSES, 15 LICENSED SUBSIDIARIES 3 PSYCHOACTIVE LICENSES, 2 TRANSFORMATION 2 TRANSFORMATION, 1 PSYCHOACTIVE LICENSES, 3 TRANSFORMATION, 1 EXPORT LICENSE (ARGENTINA) 1 EXPORT LICENSE, 1 TRANSFORMATION, 7 SEED PERMITS 1 SEED LICENSE 2 DISTRIBUTION LICENSES 1 EXPORT LICENSE, 20 SEED LICENSES LAND CAPACITY 140 HECTARES 48 HECTARES 17.2 HECTARES (IBAGUE COLOMBIA) 12.1 HECTARES 1,600 HECTARES EUROPE (AgroPro) OPTION TO EXPAND: 3,000 HECTARES OPTION TO EXPAND: 1,000 HECTARES 25 HECTARES (FUNDACIÓN DAYA/ 2019 Target: 20 HECTARES 29 HECTARES (Medicine Hat) DAYACANN IN CHILE) OPTION TO EXPAND: 1,000 8 HECTARES Aurora Sky Greenhouse 5 HECTARES (NETTAGROW THROUGH 12 HECTARES Aurora Sun Greenhouse CANNAPUR IN URUGUAY) CANNABOLAND 5 LICENSED PRODUCERS WITH A N/A N/A N/A N/A EXTENSIONS TOTAL OF 8 LICENSES CANNABOLAND 2,000 HECTARES N/A N/A N/A N/a EXTENSIONS LAND CAPACITY DISTRIBUTION 8,350 pharmacies in Colombia Cannabis Avatara (Argentina, DIXIE BRANDS (U.S). UBIQUO (MEDELLIN), 111INO, PELOTON (CANADA) CANNGROUP LTD. Off take Lexamed MarketingWorldwide, El Manantial, CannaB Patient Association2 EUGENE (AUSTRALIA) PEDANIOS (GERMANY), Madre Terra Farmatodo, ILANS, Zerenia (COLOMBIA) Agropro UAB, Farmacias Magistrales, Czech Medical Herbs INTERNATIONAL ELIXINOL (USA) JV with CANNAVA (Argentina) CANNAPUR Mino Labs NamasteMD, High Tide, MedReleaf, BRAND ENDOCA India Colorada (Colombia) DIXIE BRANDS (U.S). CanniMed Therapeutics, Cann Group, PARTNERSHIPS SD Cannabis Hempco Food and Fiber, ICC Labs, DR. KERKLANN (USA) Agropro UAB, Whistler Medical Marijuana Corporation VALUATION $25M MARKET CAP $57M MARKET CAP $400M MARKET CAP $969.1M MARKET CAP $6.3B MARKET CAP 8 www.organicmedicalgrowth.com

  9. COMPETITION / ALTERNATIVES (CONTINUED) As opposed to compe?tors: • OMG has secured mul@ple producers with various licenses therefore diversifying the risk of losing access to cri?cal licenses and extensions. • OMG has access to world-class exper@se and technology therefore able to propagate and share knowledge through its network of LPs. • OMG is strategically posi?oned to become the largest producer and distributor of cannabis products in La?n America. 9 www.organicmedicalgrowth.com

  10. BUSINESS MODEL PROFIT AT EVERY STAGE PRODUCTION TRANSFORMATION DISTRIBUTION 10 www.organicmedicalgrowth.com

  11. LP PRODUCTION • OMG has secured 8 dis?nct licensed producers (LP) to UNIT OF PRODUCTION produce and transform THC and CBD from licensed areas, represen?ng over 140 hectares with a possibility to extend to 3,000 hectares. Together, these LPs hold a total of 11 licenses (5 non-psychoac?ve, 3 psychoac?ve, 3 transforma?on) as well as 7 seed permits. OMG will implement Standard Opera?ng Procedures to control cost and quality. 11 www.organicmedicalgrowth.com

  12. CANNABOLAND PRODUCTION • Cannabolland is a business cluster that groups associated cannabis companies with cannabis related licenses for the cul?va?on, transforma?on and export of CBD oil and cannabis-based products. • Through its Joint Venture with Cannaboland, OMG ZONA SEMI OUTDOOR will have the ability to produce on the extensions of 5 LPs to produce and transform THC and CBD from a new licensed area (controlled by Cannaboland) represen?ng 140 hectares of land with the possibility to extend this produc?on to 2,000 hectares. Together, these LPs hold a total of 8 licenses. 12 www.organicmedicalgrowth.com

  13. TRANSFORMATION • Through its strategic partners, OMG will provide exper@se and technology related to the produc@on, cul@va@on and extrac@on to LPs in Colombia. This will include breeding techniques; cul?va?on, nursery and extrac?on standard opera?ng procedures. • OMG will transform cannabis oil for cosme@cs through Improfarme, a GMP cer?fied 250,000 sq [ lab for which OMG has currently an op?on to purchase. OMG will transform pharmaceu@cal (GMP and GLP) grade oil through BIOCHEM, a 2.5M sq [ facility. 13 www.organicmedicalgrowth.com

Recommend


More recommend